Short term swing trade (A): Pharmaceutical stock | Indian stock trading idea on 7 Apr 2026

NOTE

Closing Price: ₹644 (as of Apr 06, 2025)
StopLoss*: Apply on the daily close. After the first target, reset the StopLoss to your buying price.
Duration^: Approximate holding period based on the active trading days (excluding market holidays). Actual holding may vary with the market conditions.
Upside Potential#: Based on median of the suggested buy range.

Granules India Limited is a pharma company that makes and sells APIs, intermediates, and finished medicines in India and globally.

Its key products include common drugs like paracetamol and metformin, along with various prescription and OTC medicines. The company also manufactures tablets, capsules, and liquid formulations.

It serves multiple therapeutic areas such as diabetes, pain relief, infections, and CNS disorders, and also offers contract manufacturing for specialized products like peptides.

Founded in 1984, it is headquartered in Hyderabad, India.

Website: https://www.granulesindia.com/

Q3 FY26 Earnings Call Summary & Financial Highlights

Earnings Call Summary

Granules India posted a strong Q3 FY26 with revenue at ₹1,388 crore (+22% YoY) and EBITDA at ₹308 crore (+34% YoY). Margins improved to 22.2%.
Growth was broad-based, led by formulations in North America and Europe, with better product mix boosting gross margins.
Regulatory progress was positive — the USFDA issue at Gagillapur is moving forward, and Brazil’s ANVISA cleared the GLS facility.
The Peptide CDMO business is still loss-making but expected to drive future growth.
Financials improved with higher cash flows, better ROCE (16.8%), and a stronger balance sheet.

Financial Highlights

Metrics	Q3 FY26	Q2 FY26	QoQ Change	Q3 FY25	YoY Change
Revenue from Operations	1,387.90	1,297.00	7%	1,137.70	22%
Gross Margin (%)	63.90%	65.70%	-183 bps	61.7%	+216 bps
EBITDA	308.1	278.2	11%	230.3	34%
EBITDA Margin (%)	22.20%	21.50%	+75 bps	20.2%	+196 bps
PAT	150.2	130.6	15%	117.6	28%
PAT Margin (%)	10.80%	10.10%	+75 bps	10.3%	+49 bps
Cash Flow from Operations	218.7	193.7	13%	131.5	66%

Price Performance & Volume Analysis

Price Performance

Volume Analysis

Technical Analysis

Key Observations

After breaking above the neckline of the cup & handle pattern, the stock is now set up for a potential upside move.

Confident short term traders in India prefer setups where momentum is clear and hesitation is minimal.

Technical Image - Daily Timeframe

Technical Indicators

Oscillators

Indicator	Value	Zone
RSI-14	64.72	Neutral
CCI-14	131.85	OverBought
MFI	60.63	Neutral
ROC	13.58	Positive
Stochastic %K	83.22	Bullish
William %R	-5.32	OverBought

Exponential Moving Averages (EMAs)

EMA	Value	Stock Position
5 EMA	625	Above
10 EMA	614	Above
20 EMA	602	Above
50 EMA	588	Above
100 EMA	574	Above
200 EMA	562	Above

Conclusion

Granules India Stock Price Forecast

Based on our positional trading stocks, the Granules India stock price target will be INR 670 - INR 680 in the next 12-14 trading sessions.

MONEY MANAGEMENT AND TRADING RULES

Buy within the recommended price range. You may allow up to 1% flexibility beyond the range if needed.
No need to rush. The recommendation remains valid for up to 7 days, not just at market open.
Use a trailing stop-loss to protect and lock in profits.
Diversify your trading capital across our other recommended stocks to reduce risk.
Invest responsibly. Trade only with funds you can afford to lose and hedge positions where appropriate.

Analyst Summary

The research analysis is prepared by Arijit Banerjee, CMT, CFTe. He is a veteran trader and an active investor having in-depth knowledge in financial market research, advanced technical analysis, market cycle, algorithmic trading and portfolio management. Arijit is a Chartered Market Technician (CMT) accredited by CMT Association USA, the leading global authority of Technical Analysis and has been honoured by Certified Financial Technician (CFTe) from the International Federation of Technical Analysts, USA. SEBI, the regulatory body of Indian financial market also recognizes him as a Research Analyst (INH300006582).

The views expressed herein are based solely on information available publicly/internal data/other sources believed to be reliable, but is not necessarily all-inclusive and is not guaranteed as to accuracy. The recommendations provided herein is solely for informational purposes and are not intended to be and must not be taken alone as the basis for an investment/trading decision. Trading and investing are subject to market risk and the securities discussed and opinions expressed herein may not be suitable for all investors. To read the full disclosure, please click here.

Your Return Could be Much Better

Increase your Profitable!

10—12 swing trade advice / month
expected upside 6%—8% per trade
short term trade holding 1-2 weeks
minimum capital required ₹2.5 lakh
receive trade advice before 9:00 am
trade ideas by blackbox system, relied on statistics, technical, fundamental, macroeconomics and sentiment
Stocks only — no intraday or F&O